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Objectives: Considerable variation in serum sodium (Na) and chloride (Cl) is found in patients at hospital
admission. Our goal was to quantify the respective impact of drugs, comorbidities, demographic factors and
weather conditions on serum Na and Cl.
Design and methods: For 13 277 consecutive patients without terminal kidney disease admitted to the
Department of InternalMedicine of the Kantonsspital St. Gallen drug history on admission, age, sex, bodyweight,
ICD-10diagnoses, and laboratory datawere extracted fromelectronicmedical records.Weather parameters prior
to hospital admission were also integrated in a multivariate regression analysis.
Results: Both serumNa and Cl showed an asymmetric left-tailed distribution.Median (interquartile range) Na
was 138 (136/140) and Cl 104 (101/106). The distribution of sodium in patients with one or more risk factors for
SIADH was best explained by the presence of two populations: one population with a similar distribution as the
unexposed patients and a smaller population (about 25%) shifted to lower sodium levels. Lower weight, lower
blood pressure, kidney dysfunction, fever, and diabeteswere associatedwith both lowerNa andCl.Higher ambient
temperature and higher air humidity preceding admission were associated with both higher Na and Cl values.
Conclusions: Na and Cl at hospital admission are highly inﬂuenced by ambient weather conditions,
comorbidities and medication. The bimodal distribution of Na and Cl in persons exposed to risk factors for
SIADH suggests that SIADH may only affect a genetically distinct vulnerable subpopulation.
© 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
About 65% (or 2500 mmol) of total body sodium and about 85% (or
2000 mmol) of chloride are located in extracellular ﬂuid, whereas only
about 8% or 300 mmol of sodium and about 15% or 350 mmol of chlo-
ride are intracellular. The remainder of sodium (about 25–30% or
1000 mmol) is stored in bone [1,2]. Serum sodium and its accompany-
ing anions, mainly chloride and bicarbonate, are the major osmotic
active substances in the extracellular ﬂuid [2,3]. They are therefore of
paramount importance for the control of extracellular and intracellular
volume statuses. Total body sodium and chloride contents are mainly
balanced by oral intake and renal excretion. Losses by sweat and faecesdicine, Kantonsspital, CH-9007
ists. Published by Elsevier Inc. Open aplay aminor role, however ambient temperature and air humidity affect
sweating and could thus further inﬂuence serum sodium by differential
losses of electrolytes and water [2]. With the exception of acid–base
disturbances changes in content or concentration of sodium are typical-
ly paralleled by similar changes of chloride [1].
Total body sodium is mainly regulated by the renin–angiotensin–
aldosterone (RAA) system, the sympathetic nervous system and atrial
natriuretic peptide (ANP). In contrast, serum osmolality is tightly
controlled by antidiuretic hormone (ADH), which regulates free water
clearance. Thus, under normal conditions, regulation of Na and Cl (and
therefore extracellular volume) and regulation of water (and therefore
serum osmolality) are strictly separated. However, below a certain
threshold of extracellular volume depletion or expansion a non-osmotic
stimulus on ADH release begins to override the osmotic one [1].
Both hyponatraemia and hypernatraemia are associated with
increasedmortality, especially in the presence of rapid changes of intra-
cellularwater in the central nervous system (cerebral oedema, bleeding,
osmotic demyelination) [3,4]. However increased mortality is not
necessarily a causal effect of electrolyte disturbance, since dysnatraemiaccess under CC BY-NC-ND license.
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prognosis, especially shown for heart failure and liver cirrhosis [5,6].
Several clinical conditions and drugs are associated with either
increased (e.g. diabetes insipidus, hypodipsia, modulation of renal
sodium and water excretion by drugs) or decreased (e.g. syndrome of
inappropriate secretion of ADH (SIADH), congestive heart failure, liver
cirrhosis) serum sodium concentrations [3,4,7]. SIADH is considered to
be the leading cause for hyponatraemia and hypochloraemia and can
be induced by drugs or comorbidity. SIADH is deﬁned by decreased
serum osmolality, coexisting urine osmolality above 100 mOsm/kg,
urinary sodium above 40 mmol/L, euvolaemia, and the absence of
other causes for hyponatraemia. At least three mechanisms are de-
scribed: i) increased (hypothalamic) production of ADH, ii) a reset of
the so called osmostat (reduction of the hypothalamic osmolality
threshold for ADH release) and iii) a syndrome mimicking SIADH with
gain of function mutations in the V2 vasopressin receptor (NSIAD)
[8–10].
The aim of this study was to determine the relative contributions of
drugs, comorbidities, and environmental factors on serum sodium and
chloride in a large, and unselected cohort of patients admitted to a
representative tertiary referral centre. Special emphasis was placed on
determinants of SIADH.
Methods
Patients
The Kantonsspital St. Gallen is the main tertiary referral centre in
eastern Switzerland. All consecutive patients admitted to the Depart-
ment of Internal Medicine between January 2002 and July 2004 were
retrospectively included in this study. Patients on dialysis and those
with an estimated glomerular ﬁltration rate (eGFR) b 10 mL/min/
1.73 m2were excluded.We have previously published predictors of po-
tassium in the same cohort [11]. Complete drug history on admission,
age, sex, body weight, blood pressure, and comorbidities (ICD-10-
diagnoses: congestive heart failure, liver cirrhosis, diabetes, diar-
rhoea, vomiting, malabsorption, gastrointestinal bleeding, pancreatitis,
malignant diseases, sepsis, pneumonia, COPD, hyperventilation, acido-
sis, psychosis, and stroke) were derived from the electronic patient
record (Phoenix®, Parametrix, Lachen, Switzerland). The institutional
review board (Ethikkommission des Kantons St. Gallen) approved the
study and waived the need for written informed consent from the
participants.
Drug history and deﬁned daily doses
Drugswith the alleged potential to increase or decrease sodiumand/
or chloride were recorded: thiazides (6 generic substances), loop
diuretics (2), K-sparing diuretics (3), carboanhydrase inhibitors (1),
angiotensin-converting enzyme inhibitors (ACEIs; 12), angiotensin
receptor blockers (ARBs; 4), digitalis (1), betablockers (14), β2-mimetics
(5), theophylline (1), non-steroidal antiinﬂammatory drugs (NSAID;
18), corticosteroids (5), calcineurin inhibitors (2), L-Dopa or dopamine
agonists (4), antiepileptics (27), antidepressants (15), neuroleptics
(17), heparins (4), laxatives (N10), Insulin, and other antidiabetics
(12). In drug classes with different mechanisms of actions (e.g. antiep-
ileptics, antidepressants, etc.) subclasses were also deﬁned. To stan-
dardize doses within a class or subclass the daily dose of a given
substance was expressed as multiples of a deﬁned daily dose (DDD)
according to the world health organization WHO (http://www.whocc.
no/atc_ddd_index/).
Deﬁnition of SIADH-risk factors
We searched Medline for reports of SIADH associated with drug ex-
posure (e.g. amiodarone, morphine, tricyclic antidepressants, selectiveserotonin reuptake inhibitors, and others) or comorbidity (e.g. nausea,
pneumonia, lung cancer, and others). All predictors were consequently
classiﬁed as being potential “SIADH-risk factors”.
Laboratory analysis
Creatinine and electrolyte valueswere extracted from the laboratory
database. Glomerularﬁltration rate (eGFR)was estimated according the
Modiﬁcation of Diet in Renal DiseaseMDRD-short formula (186 × (SCr)
exp−1.154 × (age) exp−0.203 × 0.742 (if the subject is female) [12].
Correction for African descent was not done because this information
was not available and less than 1% of the local population is from
African descent.
Weather conditions
From the Swiss Meteorological Institute (MeteoSchweiz, Kloten,
Switzerland) we obtained tables of weather conditions for the city of
St. Gallen. These daily summary reports (including minimal, average,
and maximal daily temperature and humidity) were used as single
measurement for the day preceding hospital admission or averaged
over a period of 1 week, and 1 month before hospital admission. Since
we expected a short to intermediate effect of ambient temperature
and air humidity on electrolytes we compared the model performance
for all three measuring points.
Statistical analysis
Statistical analysis was performed using SAS release 9.2 (SAS insti-
tute Inc., Cary, NC, USA) and MATLAB (Version 7.11.0.584 (R2010b),
The MathWorks, Inc., Natick USA). Continuous variables are presented
asmeans and standard deviations (SD), or asmedians and interquartile
ranges (IQR), and categorical variables as percentages (%) and rates.
Missing values for body weight were imputed using a regression
model with the variables sex and age. If the strength of the drug or
the exact dosing schedule was not reported or ambiguous, the daily
intake of 1 DDD was assumed. If the drug was taken “on demand” the
daily intake of 1/2 DDD was assumed.
A mixed-effects regression model, controlled for clustering by
repeated admissions of individual patients was developed. To adjust
for their alleged effects on electrolytes all variables were included in
the multivariate model, irrespective of their statistical signiﬁcance.
Predeﬁned interactions (with sex, age, heart-, liver-, and kidney-
function) were only tested on univariately signiﬁcant variables and
included in the ﬁnal model if their p-valuewas b0.05. In order to detect
non-linear effects and for the exact graphical presentation we ﬁnally
introduced classes of essential predictors (e-GFR, age, weight, blood
pressure, body temperature).
In order to determine the best model for the effect of exposure with
one ormore SIADH-risk factor(s) the following hypotheses were gener-
ated: a) the distribution of exposed persons has a similar shape as the
distribution of unexposed persons but it's globally shifted to the left
(with or without an additional stretching-factor) and b) the observed
distribution is the sum of two separate distributions one of which is
identical to the distribution of the unexposed persons, and a second
distribution, which is shifted to the left (with or without an additional
stretching factor). The optimal values for the parameters in question
were found using least squares methods. The models were ranked
according to the Akaike Information Criterion.
Results
From the original cohort of 15 000 cases 283 were excluded due to
dialysis or eGFR b10 mL/min/1.73 m2, 571 were excluded due to
“haemolytic” serum, and 675 due tomissingdata for sodiumor chloride.
The present analysis is based on the data of 13 277 admissions in 9767
620 C. Bucher et al. / Clinical Biochemistry 47 (2014) 618–624patients. 5507 (41%) were females and 7770 (59%) males. Mean (±SD)
age was 63.3 (±16.0) years, body weight was 70.3 (±15.7) kg, and
eGFR was overall 74 (±33) mL/min/1.73 m2. On a yearly basis the
average (±SD) intensity of solar radiation was 127.2 (±95.3) W/m2,
mean ambient temperature was 8.9 (±7.6) °C, and mean air humidity
74.9 (±13.8) %.Distribution of electrolytes and SIADH risk factors
Overall, both electrolytes showed a skewed, left-tailed distribution
with a median (5%, 25%, 75%, and 95% percentiles) of 138 (130, 136,
140, 143) mmol/L for sodium and 104 (94, 101, 106, 107) mmol/L for
chloride. 7380 (56%) took a drug or suffered from a condition with the
potential to induce SIADH. Depending on the degree of exposure with
SIADH-risk-factors the left tail became more prominent, whilst the
position of the peak of the distribution remained almost unchanged as
outlined in Fig. 1A and B. This might be explained by a superposition
of two distinct distributions. Indeed we found strong evidence for a
double-peaked distribution of Na and even clearer for Cl, in persons
exposed to one ormore SIADH-risk factors. According to ourmathemat-
ical model about 75% of the exposed patients had a sodium-distribution
which was identical to the distribution of the unexposed group, and
about 25% of the exposed persons were part of a second distribution,
which was on average shifted by 4 mmol/L to the left (lower values)
and additionally stretched by a stretching factor of 0.92 from an anchor-
ing point of 143 mmol/L. Almost identical results were found forFig. 1. A. Distribution of sodium according to presence of SIADH-risk factors. Unadjusted
distributions of serum sodium in patients as a function of exposure to SIADH-risk factors.
All distributions are relative distributions within subgroups and the lines are smoothened
using directly adjacent observations at each point. B. Distribution of chloride according
to presence of SIADH-risk factors. Unadjusted distributions of serum chloride in patients
as a function of exposure to SIADH-risk factors. All distributions are relative distributions
within subgroups and the lines are smoothened using directly adjacent observations at
each point.chloride. In Fig. 2A and B the distribution of all exposed patients is
presented as the superposition of the two modelled populations.
Regression models for sodium and chloride
In multivariate regression higher body weight was associated with
higher sodium and chloride levels (+0.028 mmol/L Na per kg,
p b 0.0001; +0.0261 mmol/L Cl per kg, p b 0.0001; Fig. 3). In contrast
higher body temperature was associated with lower electrolytes
(linearized−0.1333 mmol/L Na per °C, p b 0.0001 and−0.079 mmol
per °C, p = 0.017; Fig. 4). Kidney function (p b 0.001) as well as
blood pressure (p b 0.0001) showed an inverse U-shaped association
with sodium and chloride (Figs. 5 and 6).
Both higher air humidity (sodium: +0.017 mmol/L per % higher
humidity, p b 0.0001; chloride: +0.015 mmol/L per % higher humidity,
p b 0.001) and higher ambient temperature (sodium: +0.033 mmol/L
per °C, p b 0.0001; chloride: +0.046 mmol/L per °C, p b 0.0001) in
theweek preceding admission had small albeit highly signiﬁcant effects
on both electrolytes (Na: Fig. 7, Cl: data not shown).
If kidney dysfunction is omitted, overall 6885 (52%) had at least one
comorbidity with alleged inﬂuence on serum sodium or chloride. The
following conditions were all associated with both lower Na and Cl:Fig. 2. A. Components of the distribution of sodium in patients exposed to SIADH-risk
factor(s). All patients exposed to one or more SIADH-risk factor(s) are combined (solid
red line). According to our mathematical model this distribution can be explained by the
superposition of two discrete populations: approximately 75% of patients with the same
distribution as unexposed patients (dashed grey line) and 25% of patients shifted to the
left (dotted grey line). B. Components of the distribution of chloride in patients exposed
to SIADH-risk factor(s). All patients exposed to one or more SIADH-risk factor(s) are
combined (solid blue line). According to our mathematical model this distribution can
be explained by the superposition of two discrete populations: approximately 75% o
patients with the same distribution as unexposed patients (dashed grey line) and 25% o
patients shifted to the left (dotted grey line).f
f
Fig. 3.Weight and Na/Cl. Linear association between higher weight and higher Na and Cl
(adjusted model; p = 0.001 for sodium and p b 0.0001 for chloride). Error bars stand for
95% conﬁdence limits.
Fig. 5.Kidney function andNa/Cl. Na and Cl declinewithworsening kidney functionwith a
possible U-shaped association (adjusted model p b 0.001 for both electrolytes). eGFR:
estimated glomerular ﬁltration rate in mL/min/1.73 m2. Error bars stand for 95% conﬁ-
dence limits.
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as well as several infections and cancers. The prevalence of comorbidi-
ties and their association with electrolytes is summarized in Table 1.
9212 (69%) took at least one drug with the potential to modify sodi-
umor chloride as outlined in Table 2. Thiazide diuretics, potassium spar-
ing diuretics but not loop diuretics were associated with signiﬁcantly
lower Na, whereas beta blockers seemed to increase both Na and Cl. A
signiﬁcant interaction between thiazide diuretics and age was identi-
ﬁed. In patients older than 65 years, the sodium and chloride lowering
effect of thiazide diuretics was signiﬁcantly stronger (−1.61 mmol/L
Na; p b 0.0001 and −2.34 mmol/L Cl; p b 0.0001 per DDD) than in
younger patients (−0.80 mmol/L Na; p = 0.003 and−1.25 mmol/L
Cl; p b 0.0001 per DDD). Antiepileptics with alleged SIADH-potential
were associated with lower Na and Cl, whereas other antiepileptics
were not.
Discussion
In an unselected population admitted to a representative tertiary
referral centre several drugs, comorbidities, demographic factors, and
weather conditions before admission have signiﬁcant effects on serum
sodium and chloride levels.
Distribution of electrolytes and syndrome of inappropriate ADH secretion
(SIADH)
A large number of diseases, drugs and other precipitating causes for
SIADH have been reported [8,13]. The occurrence and severity of SIADH
seem to vary with the type of causative drugs: the prevalence is con-
sidered to be especially high in persons taking antidepressants [14],
particularly serotonin reuptake inhibitors [15,16], antiepileptic drugs,
especially carbamazepine and oxcarbazepine [17,18] and opioids [19,20].ig. 4. Body temperature and Na/Cl. Na and Cl both decline above a threshold body
mperature (adjusted model; p b 0.0001 for sodium and p = 0.01 for chloride). Error
ars stand for 95% conﬁdence limits.
ig. 6. Blood pressure and Na/Cl. Evidence for lower Na and Cl below a threshold blood
ressure with a possible U-shaped association (adjusted model p b 0.0001 for both
ectrolytes). Mean arterial blood pressure is calculated by adding 1/3 of the difference
etween systolic and diastolic blood pressure to the diastolic blood pressure. Error bars
and for 95% conﬁdence limits.F
te
bConversely the effect of SIADH can be abolished by vasopressin receptor
antagonists (vaptans) which induce aquaresis [21]. As expected we
were able to demonstrate signiﬁcantly lower sodium in most of the
aforementioned conditions. Nevertheless the average effect in the
population was rather mild, which raises the question if only a
predisposed subpopulation is vulnerable to develop SIADH or if the
whole population is vulnerable. In the case of global susceptibility the
whole distribution curve would be expected to shift to the left in
exposed persons, whereas a bimodal distribution should result, if only
a subset of the population reacts to the stimulus. Indeed we found
strong evidence for such a bimodal distribution in our population with
a subset of about 25% of exposed persons being at risk for the develop-
ment of SIADH. It can be speculated, that a genetic variant is responsible
for this differential reaction to SIADH risk factors. It is even conceivable,
that these vulnerable persons could have somewhat lower sodium
values even without exposure to a SIADH-risk factor. This could in
part explain the clearly asymmetric distribution of the unexposed
persons, which remained evident, even when patients with other
sodium-lowering exposures were excluded from the analysis (data
not shown). Further studies are needed to conﬁrm these ﬁndings and
to possibly identify a susceptibility locus in a genome-wide associa-
tion study to predict this vulnerability for an individually tailored
pharmacotherapy.
Weather conditions preceding admission
This is the ﬁrst study to show a positive synergistic effect of both
higher ambient temperature and higher air humidity during the week
preceding measurement on sodium and chloride levels. In SwitzerlandF
p
el
b
st
Fig. 7.Air humidity and ambient temperature. This ﬁgure shows the associations between
sodium and air humidity (adjusted model; p b 0.0001) as well as ambient temperature
(p b 0.0001) averaged over one week before hospital admission (solid red lines). The
graph also shows the additive effect of these two parameters (grey grid). Similar results
were obtained for chloride (data not shown).
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very rarely. Patients do not seem to sufﬁciently correct ﬂuid losses by
sweating and are hence expected to be slightly exsiccated in summer.
We were not able to demonstrate an interaction between ambient
temperature and drugs (e.g. diuretic use).Renal function and blood pressure
We found an inverse U-shaped association between worsening
kidney function and sodium as well as chloride. The shape of this
curve suggests the presence of two competing mechanisms: sodium
and chloride initially slightly increase presumably due to lower sodium
and chloride excretion by the loss of functional nephrons, despite adap-
tive higher levels of natriuretic peptides [22]. In progressive renalTable 1
Association between comorbidity and serum sodium as well as chloride in multivariate model
Non-malignant diseases N % of patients Association wi
eGFR b 60 mL/min 3617 27.2 −0.38
Congestive heart failure 1426 10.7 0.23
Diabetes 1799 13.5 −0.72
Liver cirrhosis 249 1.9 −2.60
Alcohol abuse 239 1.8 −1.05
Vomitinga 113 0.9 −1.06
Diarrhoea 515 3.9 −1.47
Gastrointestinal bleeding 356 2.7 −0.06
Pancreatitis 168 1.3 −0.13
Sepsis 220 1.7 −1.03
Pneumoniaa 712 5.4 −1.71
COPDa 1351 10.2 −0.21
Tuberculosisa 32 0.2 −2.27
Malignant diseases
Breast cancer 246 1.9 −0.36
Lung cancera 676 5.1 −1.34
Pancreatic cancera 137 1.0 −1.91
Urothelial cancera 122 0.9 −0.99
Prostate cancera 267 2.0 −0.58
Ovarian cancera 53 0.4 −3.09
Myeloma 160 1.2 −1.22
Leukaemia 258 1.9 −0.47
Lymphoma 514 3.9 −0.20
a Stands for “SIADH-risk factor”.disease however, the reduced ability to reabsorb sodium and chloride
by renal tubuli and the diminished capacity to dilute urine outweigh
this effect and lead to a preferential retention of water compared to
sodium and chloride with the net effect of hyponatraemia and
hypochloraemia [9].
Both higher body weight and higher mean blood pressure were
associated with higher sodium and chloride. In an observational study
it is impossible to identify, whether these associations represent causal
effects or if they are induced by a common underlying mechanism.
Indeed obesity, hypertension and sodium are highly interdependent:
obesity raises blood pressure by: i) higher activity of the renin–
angiotensin–aldosterone-axis, ii) higher activity of the sympathetic ner-
vous system, iii) renal medullar compression (especially by visceral
obesity), and iv) lower levels and efﬁcacy of cardiac natriuretic peptides.
All these factors increase renal sodium and chloride reabsorption and
thus provoke a volume expansion [23,24]. Lower sodium and chloride
in the highest blood pressure quantiles are best explained by pressure
natriuresis overwhelming the autoregulation of the kidney [8,25].
Diuretics and antihypertensive drugs
Both thiazides and potassium-sparing diuretics showed a strong
dose-dependent effect on sodium and chloride blood levels. In contrast
loop diuretics had no signiﬁcant effect on sodium but they also signiﬁ-
cantly albeit onlymildly lowered chloride, presumably by inducing con-
traction alkalosis. In accordance with clinical experience the sodium-
lowering effect of thiazide diuretics was signiﬁcantly potentiated by
older age [26].
Since ACE-inhibitors and angiotensin receptor blockers also reduce
aldosterone activity it would be expected, that these drugs also induce
lower sodium levels. However, after correction for the effect of lower
blood pressure this effectwas no longer signiﬁcant. It could be speculat-
ed, that an additional inhibition of thirst and of ADH-release by these
drugsmay lead tomild hypovolaemia,which could counteract the aldo-
sterone effect [27,28].
Diseases associated with oedematous states
Congestive heart failure (CHF) is often associated with non-osmotic
stimulation of ADH and hyponatraemia [4,9,29,30]. Indeed in our(effect-size if disease is present).
th sodium p= Association with chloride p=
b0.0001 −0.42 b0.0001
0.06 0.06 0.6
b .0001 −1.02 0.0001
b .0001 −1.29 0.0002
0.0002 −2.06 b .0001
0.006 −2.85 b .0001
b .0001 −1.55 b .0001
0.8 0.62 0.01
0.0001 −1.38 0.0002
b0.0001 −0.57 0.07
b0.0001 −1.81 b .0001
0.1 −0.49 0.001
0.005 −2.49 0.004
0.2 −0.53 0.1
b0.0001 −1.56 b0.0001
b0.0001 1.85 b0.0001
0.02 0.04 0.9
0.04 −0.10 0.7
b0.0001 −3.87 b0.0001
0.008 0.48 0.3
0.2 0.08 0.8
0.4 −0.17 0.5
ment of hyponatremia. Am J Kidney Dis 2013;62:364–76.
Table 2
Association between drug exposure and serum sodium as well as chloride in multivariate model (effect size for 1 deﬁned daily dose [DDD] of drug).
Diuretics and antihypertensive drugs N % of patients Association with sodium p= Association with chloride p=
Thiazides 1108 8.3 −1.39 b0.0001 −2.05 b0.0001
Loop diuretics 2078 15.7 0.02 0.7 −0.48 b0.0001
Potassium sparing diuretics 933 7.0 −1.85 b0.0001 −0.98 b0.0001
Carboanhydrase inhibitors 35 0.3 2.19 0.1 4.06 0.008
Beta blockers 4001 30.1 0.57 b0.0001 0.28 0.03
ACE inhibitors 2430 18.3 −0.10 0.1 −0.03 0.7
Angiotensin II antagonists 931 7.0 −0.12 0.2 −0.10 0.4
CNS-active drugs
Selective serotonin reuptake inhibitorsa 527 4.0 −0.12 0.5 −0.10 0.6
Tricyclic antidepressantsa 385 2.9 0.12 0.8 −0.05 0.9
Antiepileptics with SIADH-potentiala,b 256 1.9 −1.04 0.02 −1.21 0.02
Antiepileptics without SIADH-potentialc 123 0.9 −0.12 0.8 −0.02 1.0
Morphinea 1067 8.0 −0.17 b .0001 −0.21 b .0001
Typical neuroleptics 210 1.6 0.28 0.7 0.90 0.2
Atypical neuroleptics 80 0.6 0.23 0.5 0.42 0.2
Selected other drugs
Heparinoids 862 6.5 −0.09 0.03 0.00 1.0
Calcineurin inhibitors 142 1.1 −0.51 0.004 0.24 0.3
Amiodaronea 264 2.0 −0.25 0.1 −0.50 0.1
Digoxin 423 3.2 −0.48 0.1 −1.10 0.001
Mycophenolate 65 0.5 −0.97 0.3 0.54 0.6
Corticosteroids 838 6.3 0.01 0.9 −0.03 0.3
Non-steroidal antiinﬂammatory drugs 758 5.7 0.01 1.0 0.17 0.3
Dopaminergic agentsa 150 1.1 −0.02 1.0 −0.43 0.2
Theophylline 60 0.5 −0.42 0.4 −0.34 0.5
Insulin 528 4.0 0.56 0.02 0.24 0.3
Oral antidiabetics 956 7.2 −0.31 0.1 −0.19 0.3
Laxatives 889 6.7 0.03 0.5 0.08 0.05
a Stands for “SIADH-risk factor”.
b Antiepileptics with SIADH-potential: carbamazepine, oxcarbazepine, gabapentine, lamotrigine, levetiracetam.
c Antiepileptics without SIADH-potential: barbiturates, phenytoine, topiramate, valproic acid.
623C. Bucher et al. / Clinical Biochemistry 47 (2014) 618–624unadjusted model patients with CHF also showed lower sodium values.
However after adjustment for the effect of drugs, comorbidity, kidney
dysfunction and low blood pressure (partly induced by CHF) this effect
was no longer detectable. In contrast liver cirrhosis was still associated
with a potent additional sodium-lowering potential after adjustment
for these variables. This could be explained by nitric oxide overproduc-
tion in cirrhosis, which leads to vasodilatation and secondary activation
of the sympathetic nervous systemand theRAAS aswell as non-osmotic
ADH release, which in turn leads to lower sodium levels [31,32].
Limitations of the study
This study is retrospective and strictly observational. Therefore caus-
al inference has to be drawnwith caution. The study focuses on themo-
ment of hospital admission, which often occurs in a situation of
physiologic instability. Therefore the effect size of the associations
may not be representative of steady-state conditions.
Conclusions
Sodium and chloride levels at hospital admission are highly modu-
lated by patient characteristics, drugs, and diseases. A strong additive ef-
fect of ambient temperature and air humidity on sodium and chloride
levels implies that free water losses by sweat are not fully substituted
by many patients. Our data further suggest that only a subgroup of
about 25% of the European population show a higher susceptibility to
SIADH triggers. Further studies are needed to identify the (genetic)
basis of this bimodal distribution and the consequences for individual
treatment decisions.
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